Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial-Reference-Cited by-同舟云学术

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

Published:2019-02 Issue: Volume:208 Page:65-73
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Held Claes,White Harvey D.,Stewart Ralph A.H.,Davies Richard,Sampson Shani,Chiswell Karen,Silverstein Adam,Lopes Renato D.,Heldestad Ulrika,Budaj Andrzej,Mahaffey Kenneth W,Wallentin Lars

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Alignment of site versus adjudication committee-based diagnosis with patient outcomes: insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial;Sepehrvand;Clin Trials,2016

2. Do we need to adjudicate major clinical events?;Granger;Clin Trials,2008

3. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study;Mahaffey;Curr Control Trials Cardiovasc Med,2001

4. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial;Mahaffey;J Am Coll Cardiol,2014

5. Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial;Kosmidou;EuroIntervention,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjudication of Self-reported Symptomatic Stone Recurrence in the Prevention of Urinary Stones With Hydration Trial;Urology;2024-09

2. Is Myocardial Infarction Overdiagnosed?;JAMA;2024-05-21

3. Endpoint adjudication in cardiovascular clinical trials;European Heart Journal;2023-11-03

4. Event Adjudication Is Unnecessary in Blinded Trials and May Be Detrimental;JACC: Heart Failure;2023-04

5. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events;JAMA Network Open;2022-11-21